Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 345

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Thermal burn

Not yet recruiting

Phase 2a Study Comparing Autologous Epidermal Cell Suspension (Epi-001) to Standard Meek Micrograft in Patients with Deep Dermal and Full‑Thickness Burn Wounds

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years

Primary biliary cholangitis

Not yet recruiting

Saroglitazar hemimagnesium normalizes alkaline phosphatase in primary biliary cholangitis patients with incomplete response or intolerance to ursodeoxycholic acid

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Saroglitazar hemimagnesium

Non-small cell lung cancer

Not yet recruiting

Phase III Study of Izalontamab Brengitecan with Drug Combination versus Osimertinib Alone in First‑Line EGFR‑Mutated Advanced or Metastatic Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Colitis ulcerative

Not yet recruiting

Evaluation of Upadacitinib Re‑induction in Patients with Ulcerative Colitis Who Have Lost Response to a 30 mg Maintenance Dose

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Upadacitinib

Myopathy

Not yet recruiting

Long‑term safety and tolerability of ASP2957 in boys with X‑linked myotubular myopathy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:ASP2957

Effect of Metformin on Disease Progression and OCT Biomarkers in Patients with Intermediate Age‑Related Macular Degeneration

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride

Retinoblastoma

Not yet recruiting

Carboplatin with drug combination for children with unilateral retinoblastoma undergoing enucleation: study of tumor biomarkers and relapse risk

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Carboplatin

Transitional cell carcinoma+1

Not yet recruiting

Phase 3 Study of trastuzumab brengitecan versus platinum‑based chemotherapy in adults with HER2‑positive metastatic urothelial cancer after anti‑PD‑(L)1 therapy

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Oxaliplatin-based drug combination (including bevacizumab, tislelizumab, fluorouracil, folic acid) for patients with diagnosed metastatic colorectal cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab

Phase 2 Study of Apitegromab in Patients with Facioscapulohumeral Muscular Dystrophy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Apitegromab

Cardiac failure chronic+1

Not yet recruiting

Effect of oral urea on hyponatremia and fluid overload in adults with acute and chronic heart failure

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Urea

Safety of allogeneic adipocyte-derived mesenchymal stromal cells expressing CXCR4 and IL‑10 in steroid‑refractory or ruxolitinib‑refractory acute graft‑versus‑host disease

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:CXCR4/IL10-MSCs
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.